LANTHEUS HOLDINGS INC

LNTH · NASDAQ

Updated at 2026-10-15 06:30:51

$100.00-0.02%
Today's High
$100.23
Today’s Low
$99.91
LANTHEUS HOLDINGS INC (LNTH) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$100.06
Previous Close
$100.00
Volume
936.66K
Market Cap
$6.53B
P/E Ratio
23.76X
EPS
$4.13

Previous Day Range

$99.91$100.23

52-Week Range

$50.15$111.86

Company Overview

Sector
HEALTHCARE
Industry
Health Care
Sub-industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Headquarters
201 BURLINGTON ROAD, BEDFORD, MA, UNITED STATES, 01730
Country
US
Listing Date
2015-06-25
Fiscal Year End
December
Shares Outstanding
65.11M
CIK
0001521036

Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.

Financial Metrics

Revenue

2026-06-30

$388.18M

2026-03-31

$377.33M

2025-12-31

$406.78M

2025-09-30

$384.01M

Operating Expenses

2026-06-30

$141.64M

2026-03-31

$149.59M

2025-12-31

$163.69M

2025-09-30

$178.75M

Net Income

2026-06-30

$75.02M

2026-03-31

$118.41M

2025-12-31

$54.08M

2025-09-30

$27.77M

Net Profit Margin

2026-06-30

19.32%

2026-03-31

31.38%

2025-12-31

13.29%

2025-09-30

7.23%

Earnings Per Share

2026-06-30

$1.32

2026-03-31

$1.46

2025-12-31

$1.46

2025-09-30

$1.27

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

$121.32M

2026-03-31

$183.95M

2025-12-31

$98.26M

2025-09-30

$67.73M

Effective Tax Rate

2026-06-30

20.03%

2026-03-31

24.28%

2025-12-31

23.13%

2025-09-30

34.47%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.